Recombinant Human VEGF 165 Protein 293-VE-010 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemRecombinant Human VEGF 165 Protein
CompanyR&D Systems, a Bio-Techne Brand
Price $393.00Supplier Page View Company Product Page
Catalog Number293-VE-010
SpeciesHuman
Molecule NameVEGF
Size10 ug (also 50 ug, 500 ug, 1 mg)
NCBI Full Gene Namevascular endothelial growth factor A
NCBI Gene AliasesMVCD1, VPF, VEGF
FormatLyophilized from a 0.2 µm filtered solution in Acetonitrile and TFA with BSA as a carrier protein
Molecular WeightObserved: 20-22 kDa, under reducing conditions. 39-42 kDa, under non-reducing conditions.
Theoretical: 19.2 kDa (monomer)
ApplicationsBioactivity
Conjugate/TagUnconjugated
Source/Expression SystemSf 21 (baculovirus)-derived Recombinant Human VEGF 165 Protein
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution
Purity>97%, by SDS-PAGE under reducing conditions and visualized by silver stain

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) DNA Nanoflower LYTACs Enable Efficient VEGF Degradation and Verteporfin Loading for Combined Therapy of Wet Age‐Related Macular DegenerationAdvanced ScienceMarch 1, 2026Mengxuan Li, Yan Yue, Sijin Wu, Xinyu He, Jiayi Song, Shuwen Ma, Haokun Zhang, Chenyu Xu, Song Chen, Yanming Huang, et al.COULTER, USA). 4.7 ELISA EA. hy926 cells were incubated with 10 ng/mL recombinant human VEGF protein (#293‐VE‐010, R&D Systems, USA) and various concentrations of NF for 12 h. The cell culture medium was collected,

(2) Extracellular Small RNAs in Human Milk: Molecular Profiles, Stability and Fragment-Specific Responses in Cell-Based AssaysNon-Coding RNAFebruary 9, 2026Clara Claus, Carla Borini Etichetti, Bruno Costa, Julieta B. Grosso, Juan Pablo Tosar, Uciel Chorostecki, Silvana V. SpinelliWaltham, MA, USA). HUVEC cells were cultured in RPMI 1640 medium supplemented with 15% FBS, 10 ng/mL VEGF (293-VE-010, R&D system) and 100 units/mL penicillin and streptomycin. THP1 cells were cultured in RPMI 1640 medium

(3) VEGF-A isoforms induce the expression of APLN in endothelial cells during human prenatal lung developmentFrontiers in Cell and Developmental BiologyJanuary 23, 2026Antony Hoarau, Andrew Frauenpreis, Randa Belgacemi, Emma Loeffler, Osshaya Maalouf, Ian A. Glass, Denise Al Alam, Soula Danopoulosisoforms come from R&D system (VEGF-A121: cat#4644-VS-010, VEGF-A145: cat#7626-VE-010, VEGF-A165: cat#293-VE-010, VEGF-A189: cat#8147-VE-025). Considering the supplier information about the median effective dose,

(4) Dimethyl fumarate is an inhibitor of pathological angiogenesisCellular signallingDecember 1, 2025Ng PQ, Huang K, McLellan FC, Yang M, Lennikov A, Hu Z, Chaudhary S, Appiah AC, Vuong ML, Shu DY.

(5) Endothelial RNF20 suppresses endothelial-to-mesenchymal transition and safeguards physiological angiocrine signaling to prevent congenital heart diseaseNat CommunOctober 27, 2025Yanliang Dou, Nalan Tetik-Elsherbiny, Rui Gao, Yonggang Ren, Yu-Wen Chen, Moritz Merbecks, Aadhyaa Setya, Olga Lityagina, Yinuo Wang, Evgeny Chichelnitskiy, et al.differentiation medium further supplemented with vascular endothelial growth factor A (VEGFA, R&D Systems, #293-VE-010), Activin A (R&D Systems, #338-AC), and BMP4 (the concentration was adjusted for each lot). Following

(6) Zbtb16 determines the fate plasticity of cardiovascular progenitors through IGF2BP3-mediated mRNA stabilizationCell reportsAugust 26, 2025Wang W, Lian Y, Li J, Wu Y, Li M, Wu Y, Xu R, Zhao X, Kang J, Guo X.

(7) Secretion of a VEGF-Blocking scFv Enhances CAR T-cell PotencyCancer Immunology ResearchAugust 1, 2025Valentina M. Supper, Hannah Donner, Filippo Birocchi, Alexandra Bratt, Giulia Escobar, Michael C. Kann, Sangwoo Park, Grace Martin, Felix Korell, Hana Takei, et al.NHDFs at 5,000 cells/well and treatment conditions were added (recombinant VEGF at 4 ng/ml (R&D Systems 293-VE-010), suramin sodium salt at 0.25 mg/ml (Millipore Sigma, S2671–25MG), culture supernatant from confluent

(8) Ex situ heart perfusion: A novel platform to test cardiovascular therapeutics in human heartsJHLT OpenAugust 1, 2025John Onsy Louca, Magnus Althage, Marco Öchsner, Aravinda Page, Joao Pedro Nunes, Catherine Wilson, Sanjay Sinha, Simon Messer, James Matt Bae, Mostin Hu, et al.Mesoscale Diagnostics) in combination with human VEGFA 165 protein (Recombinant Human VEGFA 165 protein, 293-VE-010, R&D Systems) used for the calibration standards and quality controls (QCs). Statistical differences

(9) Obesity Alters the Vascular Morphology and VEGF‐A Signaling in Adipose TissueFASEB BioAdvancesMay 19, 2025Yunjeong Lee, Keith Lionel Tukei, Yingye Fang, Shobhan Kuila, Xinming Liu, Princess I. Imoukhuedeethanolamine hydrochloride‐NaOH (pH 8.5) for 7 min at 10 μL/min. For kinetic analysis, analyte VEGF‐A (Cat. #293‐VE‐010, R&D Systems) was injected at concentrations of 50, 25, 12.5, 6.25, and 3.12 nM, and the association

(10) Therapeutic potential of allosteric HECT E3 ligase inhibitionCellMay 15, 2025Alexander M.K. Rothman, Amir Florentin, Florence Zink, Catherine Quigley, Olivier Bonneau, Rene Hemmig, Amanda Hachey, Tomas Rejtar, Maulik Thaker, Rishi Jain, et al."Recombinant Human CTGF/CCN2 Protein, CF",R&D,Cat#9190-CC-050 Recombinant Human HGF Protein,R&D,Cat#294-HG-005 Recombinant Human VEGF,R&D,Cat#293-VE-010 Serotonin hydrochloride,Tocris,Cat#3547 Endothelin-1,Tocris,Cat#1160 DETA NONOate,Tocris,Cat#6077 VIP,Tocris,Cat#1911/1 Bosentan,Sigma,Cat#SML1265-10MG Riociguat,Sigma,Cat#B8810-5MG Sildenafil,Simga,Cat#PZ0003-5MG U46619,Simga,Cat#D8174-1MG FK506,Sigma,Cat#F4679-5MG Rosiglitazone,Sigma,Cat#R2408-10MG MRE-269,Cayman

(11) OPN3-mediated positive regulation of angiogenesis in HUVECs through VEGFR2 interactionCommunications BiologyMarch 31, 2025Huanhuan Luo, Wei Zhang, Wen Zeng, Yu Wang, Jianglong Feng, Yinghua Lan, Xian Dong, Ting Liu, Yan Sun, Hongguang Luembryo) into fertilized eggs, which were then observed for developmental changes over 48 hpf56,57. VEGF (293-VE-010, R&D Systems, USA) was dissolved in phosphate-buffered saline (PBS, P1020, Solarbio, China) to achieve

(12) A patient-derived ovarian cancer organoid platform to study susceptibility to natural killer cellsbioRxiv : the preprint server for biologyMarch 7, 2025Mercadante M, Scheben A, Estrada J, Savas-Carstens J, Sullivan W, Housel N, Volpari T, Hebner J, Sapar M, Rusielewicz T, et al.

(13) Harnessing macrophage-drug conjugates for allogeneic cell-based therapy of solid tumors via the TRAIN mechanismNature communicationsFebruary 4, 2025Taciak B, Bialasek M, Kubiak M, Marszalek I, Gorczak M, Osadchuk O, Kurpiel D, Strzemecki D, Barwik K, Skorzynski M, et al.A1000701) supplemented with BMP4 (50 ng/ml, R&D Systems, 314-BP-010), VEGF (50 ng/ml, R&D Systems, 293-VE-010), SCF (20 ng/ml, Gibco, PHC2111), additionally supplemented with 10 µM ROCK Inhibitor (Y-27632, Sigma-Aldrich,

(14) GATA6 regulates WNT and BMP programs to pattern precardiac mesoderm during the earliest stages of human cardiogenesisbioRxiv : the preprint server for biologyJanuary 11, 2025Bisson JA, Gordillo M, Kumar R, de Silva N, Yang E, Banks KM, Shi ZD, Lee K, Yang D, Chung WK, et al.

(15) Anti-Syndecan 2 Antibody Treatment Reduces Edema Formation and Inflammation of Murine Laser-Induced CNVTransl Vis Sci TechnolJanuary 10, 2025Federico Corti, Filippo Locri, Flavia Plastino, Paola Perrotta, Krisztina Zsebo, Emma Ristori, Xiangyun Yin, Eric Song, Helder André, Michael Simonsbovine serum (FBS) without growth factors added. After 16 hours, either 1 µL of PBS (vehicle) or VEGF-A (293-VE-010; R&D Systems) at a final concentration of 100 ng/mL was added to each well. VEGF-A was allowed to induce

(16) Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophagesNature communicationsDecember 30, 2024Pickering S, Wilson H, Bravo E, Perera MR, Seow J, Graham C, Almeida N, Fotopoulos L, Williams T, Moitra A, et al.

(17) Eurycomanone inhibits osteosarcoma growth and metastasis by suppressing GRP78 expressionJournal of ethnopharmacologyDecember 5, 2024Xu W, Wang Z, Liu T, Ma X, Jiao M, Zhao W, Yu L, Hua Y, Cai Z, Li J, et al.

(18) Single-cell transcriptome analysis reveals CD34 as a marker of human sinoatrial node pacemaker cardiomyocytesNature communicationsNovember 27, 2024Lim AA, Pouyabahar D, Ashraf M, Huang K, Lohbihler M, Murareanu BM, Chang ML, Kwan M, Alibhai FJ, Tran T, et al.

(19) Comprehensive biomarker and modeling approach to support dose finding for BI 836880, a VEGF/Ang-2 inhibitorJournal of translational medicineOctober 14, 2024Keller S, Kunz U, Schmid U, Beusmans J, Büchert M, He M, Jayadeva G, Le Tourneau C, Luedtke D, Niessen HG, et al.

(20) Plug-and-play protein biosensors using aptamer-regulated in vitro transcriptionNature communicationsSeptember 12, 2024Lee H, Xie T, Kang B, Yu X, Schaffter SW, Schulman R.

Be the First to Write a Review!

Recombinant Human VEGF 165 Protein

VEGF 165 Protein

VEGF 165 Protein

VEGF 165 Protein

VEGF 165 Protein

Recombinant Human VEGF 165 Protein from R&D Systems, a Bio-Techne Brand

R&D Systems, a Bio-Techne Brand

Citations (517)

Reviews

Recombinant Human VEGF 165 Protein from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map